Anti-aging Market (By Products: Anti-wrinkle, Hair color, Ultraviolet absorption, Anti-stretch mark; By Treatment: Hair restoration, Anti-pigmentation, Adult acne therapy, Breast augmentation, Liposuction, Chemical peel; By Demography: Generation X, Baby Boomers, Generation Y, Generation Z; By Devices; By End User)- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Anti-aging Market 

5.1. COVID-19 Landscape: Anti-aging Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Anti-aging Market, By Products Type

8.1. Anti-aging Market, by Products Type, 2022-2030

8.1.1. Anti-wrinkle

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Hair color

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Ultraviolet absorption

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Anti-stretch mark

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Anti-aging Market, By Treatment Type

9.1. Anti-aging Market, by Treatment Type, 2022-2030

9.1.1. Hair restoration

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Anti-pigmentation

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Adult acne therapy

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Breast augmentation

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Liposuction

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Chemical Peel

9.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Anti-aging Market, By Demography Type 

10.1. Anti-aging Market, by Demography Type, 2022-2030

10.1.1. Generation X

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Baby Boomers

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Generation Y

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Generation Z

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Anti-aging Market, By Devices Type

11.1. Anti-aging Market, by Devices Type, 2022-2030

11.1.1. Anti-cellulite treatment

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Laser aesthetic devices

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Microdermabrasion devices

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Radio frequency devices

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Anti-aging Market, By End User Type

12.1. Anti-aging Market, by End User, 2022-2030

12.1.1. Hospitals

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Clinics

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Home healthcare

12.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Anti-aging  Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Products (2017-2030)

13.1.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.1.3. Market Revenue and Forecast, by Demography (2017-2030)

13.1.4. Market Revenue and Forecast, by Devices (2017-2030)

13.1.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Products (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Demography (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Devices (2017-2030)

13.1.7. Market Revenue and Forecast, by End User (2017-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Products (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Demography (2017-2030)

13.1.8.4. Market Revenue and Forecast, by Devices (2017-2030)

13.1.8.5. Market Revenue and Forecast, by End User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Products (2017-2030)

13.2.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.2.3. Market Revenue and Forecast, by Demography (2017-2030)

13.2.4. Market Revenue and Forecast, by Devices (2017-2030) 

13.2.5. Market Revenue and Forecast, by End User (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Products (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Demography (2017-2030)

13.2.7. Market Revenue and Forecast, by Devices (2017-2030) 

13.2.8. Market Revenue and Forecast, by End User (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Products (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Demography (2017-2030)

13.2.10. Market Revenue and Forecast, by Devices (2017-2030)

13.2.11. Market Revenue and Forecast, by End User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Products (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Demography (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Devices (2017-2030)

13.2.13. Market Revenue and Forecast, by End User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Products (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Demography (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Devices (2017-2030)

13.2.15. Market Revenue and Forecast, by End User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Products (2017-2030)

13.3.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.3.3. Market Revenue and Forecast, by Demography (2017-2030)

13.3.4. Market Revenue and Forecast, by Devices (2017-2030)

13.3.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Products (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Demography (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Devices (2017-2030)

13.3.7. Market Revenue and Forecast, by End User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Products (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Demography (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Devices (2017-2030)

13.3.9. Market Revenue and Forecast, by End User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Products (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Demography (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Devices (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Products (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Demography (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Devices (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Products (2017-2030)

13.4.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.4.3. Market Revenue and Forecast, by Demography (2017-2030)

13.4.4. Market Revenue and Forecast, by Devices (2017-2030)

13.4.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Products (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Demography (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Devices (2017-2030)

13.4.7. Market Revenue and Forecast, by End User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Products (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Demography (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Devices (2017-2030)

13.4.9. Market Revenue and Forecast, by End User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Products (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Demography (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Devices (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Products (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Demography (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Devices (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Products (2017-2030)

13.5.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.5.3. Market Revenue and Forecast, by Demography (2017-2030)

13.5.4. Market Revenue and Forecast, by Devices (2017-2030)

13.5.5. Market Revenue and Forecast, by End User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Products (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Demography (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Devices (2017-2030)

13.5.7. Market Revenue and Forecast, by End User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Products (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Treatment (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Demography (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Devices (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)

Chapter 14. Company Profiles

14.1. Unilever Group

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. GALDERMA LABORATORIES L.P.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Procter & Gamble (P&G) Company

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Nu Skin Enterprises Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Hologic Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Pierre Fabre S.A.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Shiseido Company Limited

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Candela Corporation

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Home Skinovations Ltd.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Estee Lauder

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

PROCEED TO BUY

   USD 4900.00
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample